Volume 25, Number 9—September 2019
Dispatch
Delays in Coccidioidomycosis Diagnosis and Relationship to Healthcare Utilization, Phoenix, Arizona, USA1
Rachel Ginn
, Ralph Mohty, KeriLyn Bollmann, Jessica Goodsell, Guillermo Mendez, Barrie Bradley, and John N. Galgiani
, Ralph Mohty, KeriLyn Bollmann, Jessica Goodsell, Guillermo Mendez, Barrie Bradley, and John N. Galgiani
Table
Median charges by monthly range of diagnostic delays before and after the date of coccidioidomycosis diagnosis for cohort of patients in Phoenix, Arizona, USA*
| Time from presentation to diagnosis, mo | No. patients | Before diagnosis |
After diagnosis |
Combined |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Median | Total | Median | Total | Median | Total | ||||
| <1 | 55 | $373 | $30,081 | $637 | $239,681 | $749 | $269,762 | ||
| 1–3 | 37 | $791 | $217,662 | $2,707 | $436,233 | $2,492 | $653,895 | ||
| 4–6 |
27 |
$915 |
$338,810 |
$1,199 |
$710,911 |
$2,680 |
$1,049,720 |
||
| No recorded symptoms |
20 |
NA |
NA |
$4,172 |
$854,597 |
$4,172 |
$854,597 |
||
| Overall | 139 | $637 | $586,553 | $875 | $2,241,422 | $1,231 | $2,827,974 | ||
*NA, not applicable.
Preliminary results from this study were presented in part at the 62nd Annual Coccidioidomycosis Study Group Meeting, April 14, 2018, Flagstaff, Arizona, USA.
Page created: August 20, 2019
Page updated: August 20, 2019
Page reviewed: August 20, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.